Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial (Q35006600)

5 August 2017

title

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial (English)

1 reference

Christoph Herrmann-Lingen

5 August 2017

0 references

0 references

1 reference

1 reference

20

Christoph Herrmann-Lingen

1 reference

5 August 2017

Aleksandar N Neskovic

Aleksandar N Neskovic

9

0 references

Rolf Wachter

Rolf Wachter

14

0 references

Stefan D. Anker

18

Stefan D Anker

1 reference

5 August 2017

12

Mitja Lainscak

1 reference

5 August 2017

17

Wolfram Doehner

1 reference

5 August 2017

Hans-Dirk Düngen

1

1 reference

5 August 2017

Svetlana Apostolovic

2

1 reference

5 August 2017

Simone Inkrot

3

1 reference

5 August 2017

Elvis Tahirovic

4

1 reference

5 August 2017

Agnieszka Töpper

5

1 reference

5 August 2017

Felix Mehrhof

6

1 reference

5 August 2017

Christiane Prettin

7

1 reference

5 August 2017

Biljana Putnikovic

8

1 reference

5 August 2017

Mirjana Krotin

10

1 reference

5 August 2017

Dejan Sakac

11

1 reference

5 August 2017

Frank Edelmann

13

1 reference

5 August 2017

Thomas Rau

15

1 reference

5 August 2017

Thomas Eschenhagen

16

1 reference

5 August 2017

Finn Waagstein

19

1 reference

5 August 2017

Goetz Gelbrich

21

1 reference

5 August 2017

Rainer Dietz

22

1 reference

5 August 2017

CIBIS-ELD investigators and Project Multicentre Trials in the Competence Network Heart Failure

23

1 reference

5 August 2017

publication date

23 March 2011

1 reference

European Journal of Heart Failure

5 August 2017

published in

1 reference

5 August 2017

volume

13

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

670-680

1 reference

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Fail

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

Beta-blockade in heart failure: selective versus nonselective agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

Epidemiology, aetiology, and prognosis of heart failure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study

8 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR020

Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR020

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR020

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR020

Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR020

Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101867

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

26 October 2018

1 reference

12 December 2020

Evaluation of the management of heart failure in primary care

1 reference

12 December 2020

Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure

1 reference

12 December 2020

COMET: a proposed mechanism of action to explain the results and concerns about dose

1 reference

12 December 2020

Identifiers

DOI

10.1093/EURJHF/HFR020

1 reference

5 August 2017

1 reference

5 August 2017

1 reference